PrinterPrezz Completes $16 Million Series A Financing

PrinterPrezz, Inc., a trailblazer in combining polymer and metal 3D printing, nanotechnologies and surgical expertise to design and manufacture next generation medical devices, has completed a $16 million Series A financing round which includes $9 million of new money. D. One Vision Management through its DOV Singularity Fund served as the largest financial investor and co-lead, Boutique Venture Partners served as the investment syndicate organizer and co-lead, Berkeley Catalyst Fund served as co-lead investor, and Solvay Ventures as strategic investor.
 
The funding will be utilized to expand PrinterPrezz’s engineering teams and to ramp development efforts in specialized materials and technologies to improve medical device innovation.
 
Shri Shetty, CEO of PrinterPrezz, commented, “PrinterPrezz has robust additive manufacturing technology platforms for developing next generation medical devices both with metals and polymers. We also have a platform to extend our regulatory pathway experience. PrinterPrezz continues to offer opportunities for innovative medical device companies to leverage our infrastructure and know-how to speed their time-to-market. We believe that the future of medical device development is in the joining of novel materials with proprietary technology. PrinterPrezz continues to build partnerships to develop these processes. This investment validates our model and secures our opportunity to explore nanotechnology and other applications for truly life changing innovations. I am grateful to our investors, employees and customers for their support and commitment.”
 
Dr. Rami El Assal, managing general partner and co-founder of Boutique Venture Partners that specializes in early-stage investments in life sciences and healthcare, commented, “What impresses me most about PrinterPrezz is their ability to provide an end-to-end solution for medical devices from concept to production. By addressing the needs of companies at various stages, PrinterPrezz helps speed innovation.” Dr. S. Thaddeus Connelly, general partner and co-founder of Boutique Venture Partners, added, “The recent FDA clearance of six medical devices was a clear demonstration of PrinterPrezz’s capabilities.”
 
David You, founder and CEO of D. One Vision Management, said, “We believe the Medifacturing infrastructure with the foundry ecosystem that PrinterPrezz is building will bring about a new era in the health care industry. With its platform-based approach, ability to leverage the versatility and design freedoms of additive manufacturing for medical device innovation and its R&D efforts, PrinterPrezz fits our investment philosophy perfectly, applying technology to the betterment of the global human population. We look forward to working with this enthusiastic and multi-disciplinary team to further grow the business.”
 
“Expanding healthcare solutions leveraging our high-performance polymers is a key part of Solvay’s growth strategy,” said Matt Jones, managing director of Solvay Ventures. “The cross functional team at PrinterPrezz has proven their ability to shorten the development cycle for 3D printed devices.”